A safe and efficacious Pt(ii) anticancer prodrug: design, synthesis, in vitro efficacy, the role of carrier ligands and in vivo tumour growth inhibition
Anticancer drug
DOI:
10.1039/c8cc06586a
Publication Date:
2018-12-20T12:24:08Z
AUTHORS (18)
ABSTRACT
A new Pt(<sc>ii</sc>) prodrug, developed by a combined drug development approach.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....